Status:
COMPLETED
Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial
Lead Sponsor:
Jun-Won Chung
Conditions:
Helicobacter Infected Patients
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to improve first line Helicobacter pylori eradication rate and to compare the sequential versus conventional triple therapy.
Eligibility Criteria
Inclusion
- peptic ulcer diseae
- two test positive rapid urease test, culture, histology
Exclusion
- lactating or pregnant
- previous stomach surgery
- severe underlying disease
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT01418300
Start Date
August 1 2010
End Date
December 1 2011
Last Update
April 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gil Medical Center
Incheon, South Korea